We are live on
!
Find out more
HC
Henshaw Capital Portfolio holdings
AUM
$3.07B
Turnover
11.76%
1-Year Est. Return
40.85%
This Fund
S&P 500
This Quarter
Est. Return
+6.77%
1 Year Est. Return
+40.85%
3 Year Est. Return
+128.2%
5 Year Est. Return
+170.36%
10 Year Est. Return
+567.65%
AUM
$914M
AUM Growth
+$67.7M
(+8%)
Cap. Flow
+$17.1M
Cap. Flow
% of AUM
1.87%
Top 10 Holdings %
Top 10 Hldgs %
31.66%
Holding
292
New
16
Increased
25
Reduced
16
Closed
12
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$6.32M |
| 2 |
JPMorgan Chase
JPM
|
+$3.57M |
| 3 |
Pfizer
PFE
|
+$3.16M |
| 4 |
GSK
GSK
|
+$2.84M |
| 5 |
Nordson
NDSN
|
+$528K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CLC
Clarcor
CLC
|
+$1.39M |
| 2 |
CLNY
Colony Capital, Inc.
CLNY
|
+$454K |
| 3 |
STJ
St Jude Medical
STJ
|
+$393K |
| 4 |
Idexx Laboratories
IDXX
|
+$389K |
| 5 |
Portland General Electric
POR
|
+$334K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.03% |
| 2 | Technology | 16.72% |
| 3 | Healthcare | 13.67% |
| 4 | Communication Services | 12.36% |
| 5 | Financials | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Trimble
TRMB
$14.2B
| $832K | 0.09% |
25,995
+5,768
| +29% | +$178K |
2016 Q4
1 quarter
|
|
102
Henry Schein
HSIC
$9.69B
| $822K | 0.09% |
12,334
| – | – |
2016 Q1
4 quarters
|
|
103
Vail Resorts
MTN
$5.45B
| $818K | 0.09% |
4,261
-679
| -14% | -$120K |
2016 Q1
4 quarters
|
|
|
FLIR
104
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $814K | 0.09% |
22,428
| – | – |
2016 Q1
4 quarters
|
|
105
Bio-Techne
TECH
$11.4B
| $811K | 0.09% |
31,908
+14,276
| +81% | +$369K |
2016 Q1
4 quarters
|
|
106
RELX
RELX
$66.7B
| $803K | 0.09% |
40,544
-3,969
| -9% | -$74.1K |
2016 Q1
4 quarters
|
|
107
iShares MSCI USA Quality Factor ETF
QUAL
$48.9B
| $801K | 0.09% |
11,000
| – | – |
2016 Q4
1 quarter
|
|
|
UMPQ
108
DELISTED
Umpqua Holdings Corp
UMPQ
| $780K | 0.09% |
43,941
| – | – |
2016 Q1
4 quarters
|
|
|
VAR
109
DELISTED
Varian Medical Systems, Inc.
VAR
| $770K | 0.08% |
8,448
-1,186
| -12% | -$98.9K |
2016 Q1
4 quarters
|
|
|
CHL
110
DELISTED
China Mobile Limited
CHL
| $759K | 0.08% |
13,748
+711
| +5% | +$39.7K |
2016 Q1
4 quarters
|
|
111
Global Payments
GPN
$22.3B
| $755K | 0.08% |
9,362
+718
| +8% | +$56.3K |
2016 Q1
4 quarters
|
|
|
FRC
112
DELISTED
First Republic Bank
FRC
| $731K | 0.08% |
7,793
-1,426
| -15% | -$134K |
2016 Q1
4 quarters
|
|
113
Mettler-Toledo International
MTD
$32.8B
| $727K | 0.08% |
1,519
| – | – |
2016 Q1
4 quarters
|
|
114
RPM International
RPM
$12.8B
| $687K | 0.08% |
12,485
| – | – |
2016 Q1
4 quarters
|
|
|
TMX
115
DELISTED
Terminix Global Holdings, Inc.
TMX
| $675K | 0.07% |
24,155
| – | – |
2016 Q1
4 quarters
|
|
116
East-West Bancorp
EWBC
$17.3B
| $648K | 0.07% |
12,553
| – | – |
2016 Q1
4 quarters
|
|
117
Ulta Beauty
ULTA
$26B
| $644K | 0.07% |
2,258
| – | – |
2016 Q1
4 quarters
|
|
118
Fomento Económico Mexicano
FMX
$41.2B
| $642K | 0.07% |
7,249
+1,203
| +20% | +$98K |
2016 Q1
4 quarters
|
|
119
Prudential
PUK
$29.6B
| $629K | 0.07% |
15,309
| – | – |
2016 Q1
4 quarters
|
|
|
UNVR
120
DELISTED
Univar Solutions Inc.
UNVR
| $615K | 0.07% |
20,051
| – | – |
2016 Q3
2 quarters
|
|
121
Jones Lang LaSalle
JLL
$14.3B
| $607K | 0.07% |
5,446
| – | – |
2016 Q1
4 quarters
|
|
122
Novartis
NVS
$286B
| $606K | 0.07% |
9,111
-2,860
| -24% | -$191K |
2016 Q1
4 quarters
|
|
123
Canadian National Railway
CNI
$72.9B
| $585K | 0.06% |
7,907
| – | – |
2016 Q1
4 quarters
|
|
124
Westamerica Bancorp
WABC
$1.41B
| $580K | 0.06% |
10,394
| – | – |
2016 Q1
4 quarters
|
|
125
AB InBev
BUD
$160B
| $577K | 0.06% |
5,258
| – | – |
2016 Q1
4 quarters
|
|
Similar funds
Henshaw Capital's Q1 2017 Portfolio in Review
As of Q1 2017, Henshaw Capital held 292 positions worth $914M, up 8% from $847M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Henshaw Capital's Q1 2017 filing shows 16 new, 25 increased, 16 reduced and 12 closed positions. Its largest new stake was Nordson: 4,459 shares worth $548K. The largest sale was Clarcor, an estimated $1.39M.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- Henshaw Capital's largest Q1 2017 buy was Nordson: 4,459 shares worth $548K.
- Henshaw Capital added most to Vanguard FTSE Emerging Markets ETF in Q1 2017, an estimated $6.32M increase.
- Henshaw Capital's biggest Q1 2017 reduction was Idexx Laboratories, cutting an estimated $389K.
- Henshaw Capital fully exited Clarcor in Q1 2017, selling an estimated $1.39M.
- Henshaw Capital's ten largest holdings make up 32% of its $914M portfolio in Q1 2017.
- Henshaw Capital opened 16 new positions and closed 12 in Q1 2017.
- Henshaw Capital's portfolio value rose 8% quarter-over-quarter to $914M.
Based on Henshaw Capital's 13F filing for Q1 2017, filed 28 May 2026.